GILEAD SCIENCES WILL BE ABLE TO MEET THE GLOBAL REMDESIVIR DEMAND BY OCTOBER

Highlights

• By the year-end, it plans to produce more than 2 million treatment courses
• Since January, it has increased supply of the drug more than 50-fold

Gilead Sciences said on Thursday that it will be able to meet the global deman...